Low vaccination coverage with the return of measles

This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.

It is understandable that measles is considered one of the most relevant infectious diseases in the world, quite prevalent in malnourished children, because it is known that its target audience is developing the defense mechanisms that make up the immune system, but can reach the age range from newborns to 49 years of age. In the world, the cases of the disease are worrisome, because before the implementation of public policies aimed at immunization, as highlighted by the World Health Organization in the 60s, approximately 130 million cases of measles, which appeared annually in the world, highlighting that the level of mortality is confirmed 30 million deaths worldwide. To return to the previous context, the measles outbreak has become an extremely serious problem for the health of individuals. Thus, on a global scale in 2012 there was a large reduction and the number of cases recorded, remained around 84,117 confirmed. It is noticeable that the disease is still quite prevalent in some countries, i.e. Asia, Africa, Europe and Oceania, as outbreaks are still present.